Medivizor

Title of notification

Here comes the notification
X
 
icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: BMC cancer | Added Oct 22, 2023

Evaluating the effectiveness and safety of TAS-102 plus Yttrium-90 radioembolization for the treatment of patients with colorectal cancer liver metastasis.

This study evaluated the effectiveness and safety of TAS-102 (Lonsurf; trifluridine-tipiracil) plus Yttrium-90 (Y-90) radioembolization (RE) for patients with colorectal cancer liver metastasis (CRLM) who are unresponsive to chemotherapy. The data showed that TAS-102 plus RE was safe and effective in these patients.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | Added Aug 27, 2023

Evaluating the effectiveness and safety of maintenance therapy with panitumumab plus FOLFIRI in patients with RAS wild-type metastatic colorectal cancer.

This study evaluated the effectiveness and safety of panitumumab (Vectibix) rechallenge when added to maintenance therapy with FOLFIRI {fluorouracil (FU; Adrucil), folinic acid (FA; Leucovorin), irinotecan (Camptosar)} in patients with RAS wild-type metastatic colorectal cancer (mCRC). The data showed that maintenance therapy with panitumumab plus FOLFIRI was effective with manageable side effects in these patients.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: The Oncologist | Added Jun 11, 2023

Evaluating the effectiveness of chemotherapy for patients with resectable colorectal cancer liver metastases.

This study evaluated the effectiveness of chemotherapy before surgery for the treatment of patients with resectable colorectal cancer liver metastasis (CRLM). The data showed that the addition of chemotherapy before surgery significantly improved disease-free survival (survival without any signs or symptoms of cancer) but not the overall survival in these patients.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Clinical Colorectal Cancer | Added May 28, 2023

Evaluating the health-related quality of life outcomes of second-line chemotherapy combined with either bevacizumab or cetuximab in patients with advanced colorectal cancer.

This study evaluated the health-related quality of life (HR-QoL) outcomes of second-line chemotherapy combined with either bevacizumab (Avastin) or with cetuximab (Erbitux) in patients with advanced colorectal cancer with wild-type KRAS. This study concluded that the HR-QoL outcomes were similar with both treatments in these patients.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added May 26, 2023

Comparing the effectiveness of TAS-102 versus regorafenib for the treatment of patients with metastatic colorectal cancer.

This study compared the effectiveness of TAS-102 (Lonsurf; trifluridine-tipiracil) versus regorafenib (Stivarga) for the treatment of patients with metastatic colorectal cancer (mCRC). The data showed that TAS-102 had better oncologic outcomes than regorafenib in these patients.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Journal of clinical oncology | Added May 24, 2023

Evaluating the effectiveness and safety of adding oxaliplatin (3 months vs 6 months) to 6 months of fluoropyrimidine after surgery in patients with stage II or III colon cancer.

This study evaluated the effectiveness and safety of adding oxaliplatin (Eloxatin; 3 months vs 6 months) to 6 months of fluoropyrimidine therapy such as 5-Fluorouracil (Adrucil) or capecitabine (Xeloda) as adjuvant (treatment after surgery) treatment in patients with stage II or III colon cancer. The data showed that adding 3 months of oxaliplatin to 6 months of fluoropyrimidine treatment could be considered an alternative adjuvant treatment option in patients treated with capecitabine plus oxaliplatin.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added May 22, 2023

Evaluating the effectiveness and safety of microwave ablation therapy for the treatment of lung metastases in patients with colorectal cancer.

This study evaluated the effectiveness and safety of microwave ablation (MWA) therapy for the treatment of lung metastases in patients with colorectal cancer (CRC). The data showed that MWA therapy might be a safe and effective option for these patients.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added May 20, 2023

Evaluating the effectiveness of chemotherapy before surgery for patients with colorectal cancer liver metastases.

This study evaluated the effectiveness of chemotherapy given before surgery (neoadjuvant chemotherapy; NAC) for the treatment of patients with colorectal cancer liver metastasis (CRLM) at high risk. The data showed that NAC improved the overall survival of these patients.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Targeted oncology | Added May 18, 2023

Evaluating the effectiveness and safety of trifluridine-tipiracil plus bevacizumab in patients with resistant metastatic colorectal cancer

This study evaluated the effectiveness and safety of the combination of trifluridine-tipiracil (Lonsurf) and bevacizumab (Avastin) in patients with unresponsive (refractory) metastatic colorectal cancer (mCRC) in a real-world setting. The main finding was that trifluridine-tipiracil plus bevacizumab was safe and effective in patients with mCRC in a real-world setting.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Scientific reports | Added May 16, 2023

Evaluating the effectiveness of massage therapy for chemotherapy-induced nerve disease

The study evaluated the effectiveness of massage therapy for chemotherapy-induced peripheral neuropathy (CPIN) in patients with breast and gastrointestinal (GI) cancer. The main finding of the study was that intensive massage therapy 3 times a week showed promising results in these patients. 

View

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?